
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $3.6B | -- | -- | $1.54 | -- |
08/05/2025 | Q2 | $3.5B | -- | -- | $1.41 | -- |
05/07/2025 | Q1 | $3.3B | $2.7B | $0.30 | $1.11 | -$0.81 |
02/20/2025 | Q4 | $3.3B | $3.5B | $1.65 | $1.21 | $0.44 |
11/06/2024 | Q3 | $3.3B | $3.5B | $0.97 | $1.42 | -$0.45 |
08/05/2024 | Q2 | $3.1B | $3.1B | $1.12 | $1.31 | -$0.19 |
05/08/2024 | Q1 | $2.7B | $3.2B | $0.91 | $0.85 | $0.06 |
02/21/2024 | Q4 | $2.7B | $3.4B | -$0.25 | $1.00 | -$1.25 |
11/07/2023 | Q3 | $2.8B | $2.7B | $1.57 | $1.15 | $0.42 |
08/08/2023 | Q2 | $2.7B | $3B | $0.81 | $1.04 | -$0.23 |
05/03/2023 | Q1 | -- | $2.4B | -$0.22 | -- | -- |
02/22/2023 | Q4 | -- | $2.6B | $0.25 | -- | -- |
11/08/2022 | Q3 | -- | $3.3B | $1.32 | -- | -- |
08/02/2022 | Q2 | -- | $2.6B | $1.92 | -- | -- |
05/10/2022 | Q1 | -- | $3.1B | $1.41 | -- | -- |
02/23/2022 | Q4 | -- | $4.6B | $1.87 | -- | -- |
11/02/2021 | Q3 | -- | $3.7B | $2.57 | -- | -- |
08/03/2021 | Q2 | -- | $3.7B | $1.92 | -- | -- |
05/06/2021 | Q1 | -- | $3B | $2.08 | -- | -- |
02/24/2021 | Q4 | -- | $3.7B | $2.73 | -- | -- |
11/04/2020 | Q3 | -- | $3B | $1.29 | -- | -- |
08/04/2020 | Q2 | -- | $2.4B | $1.11 | -- | -- |
04/22/2020 | Q1 | -- | $1.6B | -$0.22 | -- | -- |
02/13/2020 | Q4 | -- | $2.4B | $1.22 | -- | -- |
10/29/2019 | Q3 | -- | $2.2B | $0.90 | -- | -- |
07/16/2019 | Q2 | -- | $2.1B | $0.96 | -- | -- |
04/24/2019 | Q1 | -- | $1.7B | $0.74 | -- | -- |
02/13/2019 | Q4 | -- | $1.7B | $0.16 | -- | -- |
10/24/2018 | Q3 | -- | $2.1B | $0.85 | -- | -- |
07/17/2018 | Q2 | -- | $2.1B | $0.90 | -- | -- |
05/02/2018 | Q1 | -- | $1.7B | $0.35 | -- | -- |
01/30/2018 | Q4 | -- | $2B | $0.88 | -- | -- |
10/25/2017 | Q3 | -- | $2B | $0.62 | -- | -- |
07/19/2017 | Q2 | -- | $2.1B | $0.63 | -- | -- |
04/03/2017 | Q1 | -- | $1.6B | $0.25 | -- | -- |
02/01/2017 | Q4 | -- | $926M | $0.66 | -- | -- |
11/02/2016 | Q3 | -- | $2.3B | $0.45 | -- | -- |
07/21/2016 | Q2 | -- | $2.5B | $0.56 | -- | -- |
04/27/2016 | Q1 | -- | $2B | $0.21 | -- | -- |
02/10/2016 | Q4 | -- | -$184M | $0.40 | -- | -- |
10/27/2015 | Q3 | -- | $2.4B | $0.36 | -- | -- |
Fidelity National Financial reported $2.7B worth of top line sales in its most recent quarter.
Fidelity National Financial announced earnings per share of $0.30 which represents a miss of analyst forecast a $1.11 per share.
Fidelity National Financial reported -- that represents -- per share over the last quarter.
Fidelity National Financial's earnings are forecast to grow from $4.65 per share to $4.54 per share next year representing an increase of 15.68%.
Fidelity National Financial's next earnings date is August 5, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.